The Charlie Landers Foundation Ewing Sarcoma Research Grant 2027 provides US$20,000–US$150,000 for one year of pediatric Ewing sarcoma research. The foundation welcomes both new and established investigators proposing preclinical, translational or clinical studies with the potential to benefit patients.
Researchers can build on an existing line of work if the proposed study is distinct from work that already has funding. Projects that make sufficient progress may qualify for a second year of support.
Eligibility Criteria
- Both new and established investigators may apply.
- Applicants must hold an MD, PhD or dual MD/PhD.
- The proposed research must focus on pediatric Ewing sarcoma.
- The grant must be administered by a nonprofit institution or organization operating in the United States.
- U.S. citizenship is not required.
- The proposed work cannot overlap with an already funded study. Established investigators should explain how it differs from previously sponsored research.
Funding Details
- Award: US$20,000–US$150,000 for one year.
- Renewal: An additional US$20,000–US$150,000 may be available for a second year, subject to progress and approval.
- Eligible costs: Salary, fringe benefits, travel, supplies and equipment costing less than US$10,000 per item.
- Indirect costs: Not covered.
Deadline
- Application deadline: January 22, 2027.
- Recipient announcement: March 24, 2027.
- Funding start: July 1, 2027.
Further Information
- Official guidelines and application form. Combine the proposal and supporting documents into one PDF and upload it through the form.
- Contact: lisa@thecharlielandersfoundation.org